Alto Neuroscience Insider Trades
NYSE: ANROHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 3 · $3.57M
- Shares bought / sold
- 0 / 134.89K
- Net activity
- Net selling $3.6 million
Alto Neuroscience insider activity
Over the last 12 months, Alto Neuroscience insiders reported 10 transactions on SEC Form 4: 0 open-market purchases and 3 sales. Insiders bought $0 and sold $3.6 million worth of stock, for net insider selling of $3.6 million. The largest seller was Smith Nicholas Conrad, with $3.6 million in reported sales.
The most recent filing shows Smith Nicholas Conrad (PRESIDENT AND CFO) reporting a transaction in 55,000 shares at $2.32 on Oct 2, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put ANRO's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
ANRO insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Oct 2, 2026 | Smith Nicholas ConradPRESIDENT AND CFO | Option exercise | 55,000 | $127.60K | Form 4 |
| Sep 30, 2026 | Smith Nicholas ConradPRESIDENT AND CFO | Sale | 886 | $23.81K | Form 4 |
| Sep 30, 2026 | Smith Nicholas ConradPRESIDENT AND CFO | Sale | 23,170 | $597.29K | Form 4 |
| Sep 30, 2026 | Smith Nicholas ConradPRESIDENT AND CFO | Option exercise | 24,056 | $56.53K | Form 4 |
| Sep 29, 2026 | Smith Nicholas ConradPRESIDENT AND CFO | Sale | 110,830 | $2.95M | Form 4 |
| Sep 29, 2026 | Smith Nicholas ConradPRESIDENT AND CFO | Option exercise | 54,375 | $127.78K | Form 4 |
| Sep 29, 2026 | Smith Nicholas ConradPRESIDENT AND CFO | Option exercise | 56,455 | $132.67K | Form 4 |
| May 14, 2026 | Etkin AmitPRESIDENT AND CEO | Gift | 400,000 | — | Form 4 |
| Mar 1, 2026 | Smith Nicholas ConradCHIEF FINANCIAL OFFICER & CBO | Tax withholding | 2,806 | $55.25K | Form 4 |
| Mar 1, 2026 | Etkin AmitPRESIDENT AND CEO | Tax withholding | 6,227 | $122.61K | Form 4 |
| Jul 10, 2024 | Savitz AdamCHIEF MEDICAL OFFICER | Buy | 2,931 | $38.75K | Form 4 |
| Jul 9, 2024 | Savitz AdamCHIEF MEDICAL OFFICER | Buy | 1,388 | $18.25K | Form 4 |
| Jul 9, 2024 | Savitz AdamCHIEF MEDICAL OFFICER | Buy | 10,681 | $133.83K | Form 4 |
| Mar 28, 2024 | Smith Nicholas ConradCHIEF FINANCIAL OFFICER | Buy | 4,550 | $75.35K | Form 4 |
| Mar 28, 2024 | Smith Nicholas ConradCHIEF FINANCIAL OFFICER | Buy | 1,600 | $25.28K | Form 4 |
| Feb 6, 2024 | Apeiron Investment Group Ltd. & Apeiron Presight Capital Fund II, L.P. & Angermayer ChristianSee Remarks | Conversion | 674,658 | — | Form 4 |
| Feb 6, 2024 | Apeiron Investment Group Ltd. & Apeiron Presight Capital Fund II, L.P. & Angermayer ChristianSee Remarks | Conversion | 251,881 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4